It’s a strong belief amongst human beings that every once in a while we witness the materialization of something that changes the course of our lives forever. There is a substantial evidence to back this up, and if we look into the intricate details of our existence, we would realize that all these transformational milestones actually link-up to make us who we are today as a society. For this generation, that milestone has been technology. Often touted as a temporary phenomenon in its initial days, technology has stuck around for way longer than the critics had predicted, and it’s only getting better and more inclusive. For instance, the current version of technology has found a place for itself in almost every major sector, and from that place, it’s pulling the strings and driving growth not just for these sectors but for a country as whole. One such collaboration technology made was with the medical sector. Ever since the ropes of healthcare and tech were tied together, a new era has been underway, and with the continuous inflow of innovative ideas, it feels like the best of it is still yet to come.
Over the years, researches have been carried out to gain a better grasp of this complex mechanism that belongs to the human body. The introduction of technology into these researches has proven to encourage better efficacy levels. In an attempt to build upon these promising foundations, a gambling technology company, a virtual mental health clinic, and Rutgers university of New Jersey, are initiating a research into a topic that has remained somewhat untapped in USA. The study will largely focus on the effectiveness of the treatments for compulsive gambling and video gaming, if delivered within virtual setting.
Playtech, a Tennessee-based telehealth clinic, revealed on Wednesday that they’ll joining forces with the Centre of Gambling Studies at Rutgers, with their research being centered on creating an evidence-based model for gambling treatment that is driven by telehealth.
As Kindbrigde Research Institute is going to be used for this particular study, the CEO of the institute, Daniel Umfleet, was asked a few questions regarding the research.
“The study is to design an evidence-based telehealth model that would monitor a client’s progress from initial intake for treatment, straight through recovery, and measure their quality of life at 30, 60, 90, and 180 days post-treatment completion,” he said.
